174 related articles for article (PubMed ID: 11907129)
1. Human DQ8 can substitute for murine I-Ag7 in the selection of diabetogenic T cells restricted to I-Ag7.
Wen L; Wong FS; Sherwin R; Mora C
J Immunol; 2002 Apr; 168(7):3635-40. PubMed ID: 11907129
[TBL] [Abstract][Full Text] [Related]
2. Major DQ8-restricted T-cell epitopes for human GAD65 mapped using human CD4, DQA1*0301, DQB1*0302 transgenic IA(null) NOD mice.
Liu J; Purdy LE; Rabinovitch S; Jevnikar AM; Elliott JF
Diabetes; 1999 Mar; 48(3):469-77. PubMed ID: 10078545
[TBL] [Abstract][Full Text] [Related]
3. Islet cell autoimmunity in NOD mice transgenic for HLA-DQ8 and lacking I-Ag7.
Raju R; Munn SR; Majoribanks C; David CS
Transplant Proc; 1998 Mar; 30(2):561. PubMed ID: 9532176
[No Abstract] [Full Text] [Related]
4. Islet cell autoimmunity in NOD mice transgenic to HLA-DQ8 and lacking I-Ag7.
Raju R; Munn SR; Majoribanks C; David CS
Transplant Proc; 1998 Mar; 30(2):474. PubMed ID: 9532134
[No Abstract] [Full Text] [Related]
5. HLA-DQ8-associated T cell responses to the diabetes autoantigen phogrin (IA-2 beta) in human prediabetes.
Kelemen K; Gottlieb PA; Putnam AL; Davidson HW; Wegmann DR; Hutton JC
J Immunol; 2004 Mar; 172(6):3955-62. PubMed ID: 15004204
[TBL] [Abstract][Full Text] [Related]
6. The murine diabetogenic class II histocompatibility molecule I-Ag7: structural and functional properties and specificity of peptide selection.
Suri A; Unanue ER
Adv Immunol; 2005; 88():235-65. PubMed ID: 16227092
[TBL] [Abstract][Full Text] [Related]
7. Detection and characterization of T cells specific for BDC2.5 T cell-stimulating peptides.
You S; Chen C; Lee WH; Wu CH; Judkowski V; Pinilla C; Wilson DB; Liu CP
J Immunol; 2003 Apr; 170(8):4011-20. PubMed ID: 12682229
[TBL] [Abstract][Full Text] [Related]
8. MHC class II molecules play a role in the selection of autoreactive class I-restricted CD8 T cells that are essential contributors to type 1 diabetes development in nonobese diabetic mice.
Serreze DV; Holl TM; Marron MP; Graser RT; Johnson EA; Choisy-Rossi C; Slattery RM; Lieberman SM; DiLorenzo TP
J Immunol; 2004 Jan; 172(2):871-9. PubMed ID: 14707058
[TBL] [Abstract][Full Text] [Related]
9. Thymic positive selection and peripheral activation of islet antigen-specific T cells: separation of two diabetogenic steps by an I-A(g7) class II MHC beta-chain mutant.
Kanagawa O; Vaupel BA; Xu G; Unanue ER; Katz JD
J Immunol; 1998 Nov; 161(9):4489-92. PubMed ID: 9794372
[TBL] [Abstract][Full Text] [Related]
10. The regulatory role of DR4 in a spontaneous diabetes DQ8 transgenic model.
Wen L; Chen NY; Tang J; Sherwin R; Wong FS
J Clin Invest; 2001 Apr; 107(7):871-80. PubMed ID: 11285306
[TBL] [Abstract][Full Text] [Related]
11. Major histocompatibility complex class II molecules can protect from diabetes by positively selecting T cells with additional specificities.
Lühder F; Katz J; Benoist C; Mathis D
J Exp Med; 1998 Feb; 187(3):379-87. PubMed ID: 9449718
[TBL] [Abstract][Full Text] [Related]
12. Modulation of insulitis and type 1 diabetes by transgenic HLA-DR3 and DQ8 in NOD mice lacking endogenous MHC class II.
Kudva YC; Rajagopalan G; Raju R; Abraham RS; Smart M; Hanson J; David CS
Hum Immunol; 2002 Nov; 63(11):987-99. PubMed ID: 12392851
[TBL] [Abstract][Full Text] [Related]
13. Type 1 diabetes-predisposing MHC alleles influence the selection of glutamic acid decarboxylase (GAD) 65-specific T cells in a transgenic model.
Abraham RS; Wen L; Marietta EV; David CS
J Immunol; 2001 Jan; 166(2):1370-9. PubMed ID: 11145722
[TBL] [Abstract][Full Text] [Related]
14. Structure of a human insulin peptide-HLA-DQ8 complex and susceptibility to type 1 diabetes.
Lee KH; Wucherpfennig KW; Wiley DC
Nat Immunol; 2001 Jun; 2(6):501-7. PubMed ID: 11376336
[TBL] [Abstract][Full Text] [Related]
15. I-Ag7-mediated antigen presentation by B lymphocytes is critical in overcoming a checkpoint in T cell tolerance to islet beta cells of nonobese diabetic mice.
Noorchashm H; Lieu YK; Noorchashm N; Rostami SY; Greeley SA; Schlachterman A; Song HK; Noto LE; Jevnikar AM; Barker CF; Naji A
J Immunol; 1999 Jul; 163(2):743-50. PubMed ID: 10395666
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic infiltration but not diabetes occurs in the relative absence of MHC class II-restricted CD4 T cells: studies using NOD/CIITA-deficient mice.
Mora C; Wong FS; Chang CH; Flavell RA
J Immunol; 1999 Apr; 162(8):4576-88. PubMed ID: 10201997
[TBL] [Abstract][Full Text] [Related]
17. Peptide-MHC class II dimers as therapeutics to modulate antigen-specific T cell responses in autoimmune diabetes.
Masteller EL; Warner MR; Ferlin W; Judkowski V; Wilson D; Glaichenhaus N; Bluestone JA
J Immunol; 2003 Nov; 171(10):5587-95. PubMed ID: 14607967
[TBL] [Abstract][Full Text] [Related]
18. Expression and function of transgenic HLA-DQ molecules and lymphocyte development in mice lacking invariant chain.
Rajagopalan G; Smart MK; Krco CJ; David CS
J Immunol; 2002 Aug; 169(4):1774-83. PubMed ID: 12165499
[TBL] [Abstract][Full Text] [Related]
19. MHC-mismatched mixed chimerism mediates thymic deletion of cross-reactive autoreactive T cells and prevents insulitis in nonobese diabetic mice.
Racine JJ; Zhang M; Wang M; Morales W; Shen C; Zeng D
J Immunol; 2015 Jan; 194(1):407-17. PubMed ID: 25429069
[TBL] [Abstract][Full Text] [Related]
20. Increased entry into the IFN-gamma effector pathway by CD4+ T cells selected by I-Ag7 on a nonobese diabetic versus C57BL/6 genetic background.
Koarada S; Wu Y; Ridgway WM
J Immunol; 2001 Aug; 167(3):1693-702. PubMed ID: 11466393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
